Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Psychiatry Res ; 269: 517-523, 2018 11.
Article in English | MEDLINE | ID: mdl-30195746

ABSTRACT

Immunological abnormalities are increasingly reported in people with schizophrenia, but no clear functional biomarkers associated with genetic correlates of the disease have been found. Regulatory T cells (Tregs) are key immunoregulatory cells involved in the control of inflammatory processes and their functions are directly related to the human leucocyte antigen (HLA) gene, which has been implicated in schizophrenia genetic studies. However, there is a lack of studies reporting Treg status in people with schizophrenia. In the current study, the proportion of circulating Tregs was examined using flow cytometry in 26 medicated participants with schizophrenia and 17 healthy controls. Psychiatric symptoms and cognitive function were evaluated using the Scale for the Assessment of Negative Symptoms, the Brief Psychiatric Rating Scale, and the MATRICS Consensus Cognitive Battery. The proportion of Tregs was found to be significantly greater in the schizophrenia group compared to healthy controls. No differences were observed in total lymphocyte counts or CD3+ and CD4+ T cells, confirming a specific effect for Tregs. Elevated Tregs in schizophrenia correlated with fewer negative symptoms, a core domain of the illness. These results suggest that Tregs may contribute to improved negative symptoms in schizophrenia, possibly by counteracting on-going inflammatory processes.


Subject(s)
Antipsychotic Agents/therapeutic use , Schizophrenia/blood , T-Lymphocytes, Regulatory , Adult , Female , Flow Cytometry , Humans , Male , Middle Aged , Schizophrenia/drug therapy
2.
Psychiatr Q ; 89(4): 937-946, 2018 12.
Article in English | MEDLINE | ID: mdl-30051373

ABSTRACT

Recent literature suggests that schizophrenia is linked to an abnormal response of the immune system. Interferon-γ is a cytokine that acts as a mediator between immune stimulation and the kynurenine pathway and may be related to cognitive abilities. The objectives of the present study are to determine if serum cytokines are correlated with cognitive function differently in patients with schizophrenia compared to controls. Fourteen midlife (30-70 year-old) females with DSM-IV diagnosis of schizophrenia or schizoaffective disorder and 13 midlife control females were analyzed. Cytokines were collected from serum blood draws and analyzed at the Cytokine Core Lab at the University of Maryland, Baltimore. The RBANS, HVLT-R, and UPSA were performed to measure cognition and social performance. The results demonstrate a non-significant difference between interferon-γ levels in women with schizophrenia compared to controls, but this cytokine appears to correlate to cognitive abilities differently in these groups. There were several significant negative correlations between interferon-γ and cognition in midlife patients with schizophrenia, but only one in the midlife control group. The negative correlations between interferon-γ and cognition in patients with schizophrenia suggest the hypothesis that inflammation and the kynurenine pathway have important roles in this disorder.


Subject(s)
Cognition/physiology , Cognitive Dysfunction , Cytokines/blood , Inflammation , Interferon-gamma/blood , Psychotic Disorders , Schizophrenia , Adult , Age Factors , Aged , Cognitive Dysfunction/blood , Cognitive Dysfunction/immunology , Cognitive Dysfunction/physiopathology , Female , Humans , Inflammation/blood , Inflammation/immunology , Middle Aged , Psychotic Disorders/blood , Psychotic Disorders/immunology , Psychotic Disorders/physiopathology , Schizophrenia/blood , Schizophrenia/immunology , Schizophrenia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...